Mirae Asset Global Investments Co., Ltd. Reneo Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Reneo Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 998 shares of RPHM stock, worth $1,377. This represents 0.0% of its overall portfolio holdings.
Number of Shares
998Holding current value
$1,377% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RPHM
# of Institutions
67Shares Held
29.3MCall Options Held
51.7KPut Options Held
0-
Nea Management Company, LLC Timonium, MD4.79MShares$6.6 Million0.68% of portfolio
-
Tang Capital Management LLC San Diego, CA3MShares$4.13 Million0.55% of portfolio
-
Highbridge Capital Management LLC New York, NY2.92MShares$4.02 Million0.94% of portfolio
-
Carlyle Group Inc. Washington, DC2.7MShares$3.72 Million0.49% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.67MShares$3.69 Million2.88% of portfolio
About Reneo Pharmaceuticals, Inc.
- Ticker RPHM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,479,600
- Market Cap $33.8M
- Description
- Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...